Listed equity
Caplin Point Laboratories
कैपलिन पॉइंट · કેપલિન લેબ્સ
EOD close · 1 Oct 2026
Range-bound — awaiting direction.
Now at 71% of its 52-week range
Last 30 sessions
+4.8%Phase indicator
Range-bound — awaiting direction.
Delivery conviction
Lifetime story
Caplin Point Laboratories is up 1462066.7% from its lifetime low of ₹0.18 on 27 Feb 2002. ₹10,000 invested then would be worth ₹14,62,16,667 today (47.7% CAGR over 24.6 years). Lifetime high of ₹2990.60 was set on 24 Sept 2026 (currently -12.0% below).
30-day conviction trend
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 47.70 | 30.09 |
| P/Bsubs material | 9.23 | 5.32 |
| Price / Cash flowsubs material | 44.97 | 27.12 |
| Dividend yield | 0.30% | 0.30% |
| Book value / sharesubs material | 285.60 ₹ | 495.39 ₹ |
| EPS (TTM)subs material | 55.22 ₹ | 87.53 ₹ |
Returns ladder
How this page is produced
Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 1 Oct 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.
Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.
This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.